Ignyta Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters??? Option To Purchase Additional Shares Post author:Sam Post published:May 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017 Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017 What You Need to Know About Shepherd Therapeutics January 16, 2018
Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017
Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017